[Congress] Biotech Outsourcing Strategies - 19-20 June - Basel - Switzerland

[Congress] Biotech Outsourcing Strategies - 19-20 June - Basel - Switzerland 

Christophe Parsy, Drug Discovery Business Development Director and Mouhssin Oufir, DMPK & Bioanalytical Sciences Department Head, will be attending the Biotech Outsourcing Meeting.

We propose our Research and Development expertise in small molecules for any company to outsource new drug candidate generation by providing an Integrated Drug Discovery Service as a package or on a fee for service basis including:

  • Medicinal Chemistry
  • Pharmacology
  • DMPK
  • Safety and Toxicity 

Throughout your drug development process, we also offer you:

  • Our integrated Bioanalysis Service in GPx environment for both NCE & biologics:
    • Analysis of your New Chemical and Biological Entities
    • Analysis of membrane proteins
    • Immuno-analysis
  • Our DMPK expertise 
    • Early in vitro/in vivo ADME
    • Animal Pk and metabolism
    • Human Pk and metabolism

Arrange a meeting directly on the B2B plaform to meet our experts.

I fix a meeting!

 

[Congress] Anglo-Nordic Medicinal Chemistry Symposium – 11-14 June – Snekkersten – Denmark

[Congress] Anglo-Nordic Medicinal Chemistry Symposium  – 11-14 June –  Snekkersten –  Denmark 

Don’t miss the opportunity to listen to Dr. Christopher Housseman!

[Talk] Nanocyclix: Next Generation Kinase Therapeutics given by Dr. Christopher Housseman – Program Director – flash oral presentation about #Nanocyclix® technology: potency & selectivity to create opportunities in new therapeutic areas.
When? Wednesday, 12th June at 2:00pm!

[Poster] Nanocyclix: next generation kinase therapeutics | A chemocentric approach for the discovery of selective kinase inhibitors
And pop in to see our poster on #MedicinalChemistry & discover how #macrocyclisation is applied within Oncodesign’s projects leading to a Nanocyclix® platform.

I read the abstract!

%MCEPASTEBIN%

[Congress] BIO International Convention - 3-6 June - Philadelphia - USA

[Congrès] BIO International Convention - 3-6 Juin -Philadelphie 

Come and meet Dr. Fabrice Viviani, Head of the Experimentation Division and Dr. Christophe Parsy, Drug Discovery, Business Development Director, during BIO international conference networking.
Discover our unique Drug Discovery platform from patient to diagnostic and therapeutic solution.
Fix a meeting now using the BIO One-on-One Partnering platform to discuss your drug development needs!

I fix a meeting!

%MCEPASTEBIN%

[Congress] R&D series EU - 11-12 June - Berlin - Germany

[Congrès] R&D series EU – 11-12 Juin – Berlin - Allemagne  

Oncodesign is proud to be a sponsor of the R&D Europe Series!
Come listen to Dr. Alexis Denis and explore Nanocyclix, a technology based on the macrocyclization of small Lead-like molecules.

[TALK] to figure out how we can support you in your drug development!

Speaker: Alexis Denis, Head of Discovery, will talk about the Nanocyclix platform!

When: 12th June, 2019 - 9.00 am
Track: Discovery chemistry & drug design congress
Stream: Medicinal chemistry and drug design: novel approaches

Title: Make it cyclic: A paradigm for the discovery of selective kinases inhibitors “Nanocyclix”

"Cyclization in drug discovery is a growing paradigm. We have developed an Integrated Drug Discovery platform Nanocyclix to synthesize small libraries of macrocycles and design specific molecules through SBDD to identify new kinases inhibitor. Nanocyclix molecule are in the drug-like space and display nM potencies and good selectivity across the kinome.  Nanocyclix paradigm will be exemplified at the level of H2L and beyond in Oncology and Immuno-inflammation to illustrate the value and potential of the cyclization approach."

I download the flyer!

I fix a meeting!

%MCEPASTEBIN%

By closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them.